Simplex Trading
CBIO

Simplex Trading’s Crescent Biopharma CBIO Stock Holding History

Simplex Trading’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,287
Closed -$48K – 9039
2025
Q1 		$48K Buy
+2,287
New +$61.2K ﹤0.01% 5803
2024
Q3 		– Sell
-49
Closed -$1K – 8889
2024
Q2 		$1K Sell
49
-62
-56% -$6.45K ﹤0.01% 8468
2024
Q1 		$33K Buy
111
+105
+1,750% +$31.4K ﹤0.01% 6664
2023
Q4 		$1K Buy
+6
New +$933 ﹤0.01% 8489
2023
Q1 		– Sell
-10
Closed -$3K – 9404
2022
Q4 		$3K Buy
+10
New +$1.47K ﹤0.01% 8363
2022
Q2 		– Sell
-30
Closed -$3K – 10348
2022
Q1 		$3K Sell
30
-667
-96% -$78.3K ﹤0.01% 9697
2021
Q4 		$100K Buy
697
+496
+247% +$90K ﹤0.01% 6247
2021
Q3 		$46K Hold
201
– – ﹤0.01% 7597
2021
Q2 		$46K Buy
201
+200
+20,000% +$50.9K ﹤0.01% 7742
2021
Q1 		$31K Hold
1
– – ﹤0.01% 7084
2020
Q4 		$39K Buy
+1
New +$350 ﹤0.01% 6422
2020
Q3 		– Hold
0
– – – 7281
2019
Q2 		– Hold
0
– -$14K – 7349
2019
Q1 		– Hold
0
– – – 5936
2018
Q3 		– Hold
0
– -$12K – 7629
2018
Q2 		– Hold
0
– – – 6219
2018
Q1 		– Hold
0
– -$1K – 6392
2017
Q4 		– Hold
0
– – – 5509
2017
Q3 		– Hold
0
– – – 4781
2017
Q2 		– Hold
0
– – – 5604

Other funds holding CBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Simplex Trading's CBIO Position: Q2 2024 in Review

Simplex Trading sold out of Crescent Biopharma (CBIO) in Q2 2024, closing a stake of 907 shares — an estimated $94.3K sold.

Simplex Trading first reported a position in CBIO in Q2 2017 and held it in 20 quarters. The position peaked at $280K in Q1 2019. 35 funds tracked by Wall St. Rank hold CBIO as of Q2 2024.

  • Simplex Trading reported no remaining Crescent Biopharma position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 907 Crescent Biopharma shares in Q2 2024, an estimated $94.3K.
  • Simplex Trading first reported a position in Crescent Biopharma in Q2 2017 and held it in 20 quarters.
  • Simplex Trading's Crescent Biopharma position peaked at $280K in Q1 2019.
  • 35 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.